Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021

Publisher Name :
Date: 07-Jul-2016
No. of pages: 221
Inquire Before Buying

The point-of-care diagnostics market is expected to reach USD 36.96 billion by 2021, at a CAGR of 9.8% from 2016 to 2021.

The growth of the overall point-of-care diagnostics market is driven by factors such as prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe. In addition, healthcare decentralization, miniaturization of POC testing devices, increasing number of conferences and events, and POC tests with multiplexing capabilities are offering new growth opportunities for players in the point-of-care diagnostics market. On the other hand, stringent and time-consuming regulatory policies and pricing pressure owing to reimbursement cuts and budget constraints are the key challenges faced by the market players involved in the POC diagnostics market.

In this report, the point-of-care diagnostics market has been segmented on the basis of product (covering glucose monitoring testing kits, cardio metabolic testing kits, infectious disease testing kits, and urinalysis testing kits, among others), mode of prescription (OTC and prescription-based testing kits), end-users (professional diagnostic centers, home care, and research laboratories), and region (North America, Europe, APAC, and RoW). On the basis of products, the glucose monitoring kits segment is estimated to account for the largest share of the point-of-care diagnostics market in 2016. Rising diagnosis of diabetes, ongoing technological advancements in devices used for self-monitoring blood glucose level, and growing patient awareness towards POC testing is driving the growth of this segment across the globe.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the point-of-care diagnostics market in 2016, followed by Europe. A number of factors such as growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives are contributing to the growth of the North American point-of-care diagnostics market. However, rising pricing pressure and slow approval of multi-analytic POC products is limiting the growth of point-of-care diagnostics market in North America.

The point-of-care diagnostics market consists of a large number of big, medium, and small-sized companies. As of 2015, the point-of-care diagnostics market was dominated by Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), and Alere, Inc. (U.S.). New product launches and product approvals; partnerships, agreements, and collaborations; acquisitions; and expansions were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the point-of-care diagnostics market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis—market share analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the global point-of-care diagnostics market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned four strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on point-of-care diagnostic devices offered by the top 10 players in the point-of-care diagnostics market. The report analyzes the point-of-care diagnostic devices market by product and region

  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the point-of-care diagnostics market

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various point-of-care diagnostics devices across four geographies

  • Competitive Assessment: Assessment of market shares, strategies, and products of leading players in the point-of-care diagnostics market

Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation Methodology
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Research Design
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: Market Growth Rate, By Product (2016–2021)
4.3 Geographic Analysis: Market Size, By Mode of Prescription, 2016 vs 2021
4.4 Market, By End User and Region, 2016 (USD Million)

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Infectious Diseases in Developing Countries
5.3.1.2 Increasing Incidence of Lifestyle Diseases
5.3.1.3 Rising Usage of Home-Based POC Devices
5.3.1.4 Growing Government Support
5.3.1.5 Private Investments and Venture Capital Activities
5.3.1.6 Technological Advancements and New Product Launches
5.3.1.7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
5.3.1.8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
5.3.1.9 Rising Number of Clia-Waived POC Tests
5.3.2 Restraints
5.3.2.1 Product Recalls
5.3.2.2 Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints Hampering Profits
5.3.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
5.3.3 Opportunities
5.3.3.1 Emerging Markets (India, China, and Brazil) to Pave New Growth Avenues
5.3.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
5.3.3.3 Increasing Number of Conferences and Events
5.3.3.4 Miniaturization of POC Testing Devices
5.3.3.5 POC Tests With Multiplexing Capabilities
5.3.4 Challenges
5.3.4.1 Lack of Alignment With Definitive Central Lab Methods
5.3.4.2 Disadvantages of POC Testing Over Central Lab Methods
5.3.4.3 Inadequate Knowledge About Use of POC Devices in Professional Settings
5.3.4.4 Reluctance Towards Changing Existing Treatment Practices
5.3.5 Burning Issues
5.3.5.1 Unfavorable Reimbursement Limiting the Adoption of POC Tests
5.3.5.2 High Cost of Devices—A Prime Concern
5.3.5.3 Negative Public Perception Related to POC Tests

6 Industry Trends
6.1 Introduction
6.2 Industry Trends
6.2.1 Standardization of POC Testing Devices
6.2.2 Acquisition of Small Players
6.2.3 Growing Focus on Microfluidics-Based POC Devices
6.2.3.1 Microfluidics-Based Loc Devices Will Bring Laboratory Testing to the Patient’s Fingertips
6.2.3.2 Evolution of Paper-Based Microfluidic POC Diagnostic Devices
6.3 Pricing and Cost Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
6.5 Strategic Benchmarking
6.5.1 Technology Integration & New Product Launches
6.5.2 Incorporation of Wireless Technology in POC Devices

7 Point-Of-Care Diagnostics Market, By Product
7.1 Introduction
7.2 Glucose Monitoring Kits
7.3 Cardiometabolic Monitoring Kits
7.3.1 Cardiac Markers
7.3.2 Blood Gas/Electrolytes Testing Kits
7.3.3 HBA1C Testing Kits
7.3.4 LIPID Testing Kits
7.4 Infectious Disease Testing Kits
7.4.1 Influenza Testing Kits
7.4.2 HIV Testing Kits
7.4.3 Hepatitis C Testing Kits
7.4.4 Sexually Transmitted Diseases (STDs) Testing Kits
7.4.5 Tropical Diseases Testing Kits
7.4.6 Healthcare-Associated Infection Testing Kits
7.4.7 Respiratory Infections Testing Kits
7.4.8 Other Infectious Disease Testing Kits
7.5 Coagulation Monitoring Kits
7.5.1 PT/INR Testing Kits
7.5.2 Activated Clotting Time (ACT/APTT) Testing Kits
7.6 Pregnancy and Fertility Testing Kits
7.6.1 Pregnancy Testing Kits
7.6.2 Fertility Testing Kits
7.7 Tumor/Cancer Markers
7.8 Urinalysis Testing Kits
7.9 Cholesterol Test Strips
7.10 Hematology Testing Kits
7.11 Drugs-Of-Abuse Testing Kits
7.12 Fecal Occult Testing Kits
7.13 Other POC Testing Kits

8 Point-Of-Care Diagnostics Market, By Prescription Mode
8.1 Introduction
8.2 Prescription-Based Testing Kits
8.3 OTC Testing Kits Market

9 Point-Of-Care Diagnostics Market, By End User
9.1 Introduction
9.2 Professional Diagnostic Centers
9.2.1 Hospitals/Critical Care Settings
9.2.2 Outpatient Healthcare Settings
9.2.3 Ambulatory Care Settings
9.3 Research Laboratories
9.4 Home Care
9.5 Others

10 Point-Of-Care Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Growing Prevalence of Lifestyle Diseases and Rising Geriatric Population
10.2.1.2 Increasing Government and Venture Capital Funding
10.2.1.3 Growing Number of Product Approvals Using Clia Waiver
10.2.1.4 Nih Support for the Development of POC Testing Devices
10.2.1.5 Slow Inflow of Multi-Analyte POC Devices
10.2.2 Canada
10.2.2.1 Expanding Patient Population Base
10.2.2.2 Increasing Focus of Players on the Canadian Market
10.2.2.3 Increasing Government Initiatives
10.2.2.4 Lack of Reimbursement and Awareness
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Number of Conferences
10.3.1.2 Ongoing Development of Novel Products
10.3.1.3 Rising Incidence of Diabetes and Cancer in Germany
10.3.1.4 Low Reimbursement Affecting Market Growth in the Country
10.3.2 France
10.3.2.1 Increasing Reimbursement for Point-Of-Care Tests
10.3.2.2 High Prevalence of Diabetes in France
10.3.3 U.K.
10.3.3.1 Growing Number of New Product Launches
10.3.3.2 Increasing Government Support for POCt Devices
10.3.3.3 Budget Constraints Hampering Market Growth
10.3.4 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.1.1 Growing Initiatives By Market Players
10.4.1.2 Increasing Demand for Rapid Flu Tests in Japan
10.4.1.3 Centralized Healthcare Delivery System
10.4.2 China
10.4.2.1 Increasing Partnerships and Joint Ventures Fueling Market Growth
10.4.2.2 Increasing Support From Government and Private Companies
10.4.2.3 Poor Reimbursement and Time-Consuming Product Registration Procedure
10.4.3 India
10.4.3.1 Increasing Prevalence of Target Diseases
10.4.3.2 Growing Government Initiatives
10.4.3.3 Conferences
10.4.3.4 Lack of Reimbursement and Insurance Coverage Hampering Market Growth
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)
10.5.1 Increasing Patient Population in Africa
10.5.2 Huge Patient Base for Respiratory Diseases
10.5.3 Growing Initiatives By Market Players

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches,Product Enhancements, and Product Approvals
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Product Showcase and Product Recall
11.3.4 Acquisitions
11.3.5 Other Strategies

12 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.3 Abbott Laboratories, Inc.
12.4 Siemens AG
12.5 Alere Inc.
12.6 Johnson & Johnson
12.7 Instrumentation Laboratory (A Werfen Company)
12.8 Nova Biomedical
12.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.10 Becton, Dickinson and Company
12.11 PTs Diagnostics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Other Developments
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables

Table 1 Point-Of-Care Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 2 Point-of-Care Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 3 Glucose Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 4 Cardiometabolic Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 5 Cardiometabolic Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 6 Cardiac Markers Market Size, By Region, 2014–2021 (USD Million)
Table 7 Blood Gas/Electrolytes Market Size, By Region, 2014–2021 (USD Million)
Table 8 HBA1C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 9 LIPID Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 10 Infectious Disease Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 11 Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 12 Influenza Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 13 HIV Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 14 Hepatitis C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 15 STD Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 16 Tropical Diseases Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 17 Healthcare-Associated Infection Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 18 Respiratory Infections Testing Kits Market Size, By Region, 2014–-2021 (USD Million)
Table 19 Other Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 20 Coagulation Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 21 Coagulation Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 PT/INR Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 ACT/APTT Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 24 Pregnancy and Fertility Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 25 Pregnancy and Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 26 Pregnancy Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 27 Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 28 Tumor/Cancer Markers Market Size, By Region, 2014–2021 (USD Million)
Table 29 Urinalysis Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 30 Cholesterol Test Strips Market Size, By Region, 2014–2021 (USD Million)
Table 31 Hematology Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 32 Drugs-Of-Abuse Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 33 Fecal Occult Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other POC Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 35 Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 36 Prescription-Based Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 37 OTC Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 38 Market Size, By End User, 2014-2021 (USD Million)
Table 39 Professional Diagnostic Centers Market Size, By Type, 2014-2021 (USD Million)
Table 40 Professional Diagnostic Centers Market Size, By Region, 2014-2021 (USD Million)
Table 41 Research Laboratories Market Size, By Region, 2014-2021 (USD Million)
Table 42 Home Care Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 43 Other End Users Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 44 Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 45 North America: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 46 North America: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 47 North America: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 48 North America: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 49 U.S.: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 50 U.S.: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 51 U.S.: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 52 Canada: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 53 Canada: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 54 Canada: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 55 Europe: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 56 Europe: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 57 Europe: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 58 Europe: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 59 Germany: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 60 Germany: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 61 Germany: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 62 France: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 63 France: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 64 France: Market Size, By End User, 2014-2021 (USD Million)
Table 65 U.K.: Market Size, By Product, 2014-2021 (USD Million)
Table 66 U.K.: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 67 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 68 RoE: Market Size, By Product, 2014-2021 (USD Million)
Table 69 RoE: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 70 RoE: Market Size, By End User, 2014-2021 (USD Million)
Table 71 APAC: Market Size, By Country, 2014-2021 (USD Million)
Table 72 APAC: Market Size, By Product, 2014-2021 (USD Million)
Table 73 APAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 74 APAC: Market Size, By End User, 2014-2021 (USD Million)
Table 75 Japan: Market Size, By Product, 2014-2021 (USD Million)
Table 76 Japan: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 77 Japan: Market Size, By End User, 2014-2021 (USD Million)
Table 78 China: Market Size, By Product, 2014-2021 (USD Million)
Table 79 China: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 80 China: Market Size, By End User, 2014-2021 (USD Million)
Table 81 India: Market Size, By Product, 2014-2021 (USD Million)
Table 82 India: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 83 India: Market Size, By End User, 2014-2021 (USD Million)
Table 84 RoAPAC: Market Size, By Product, 2014-2021 (USD Million)
Table 85 RoAPAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 86 RoAPAC: Market Size, By End User, 2014-2021 (USD Million)
Table 87 RoW: Market Size, By Product, 2014-2021 (USD Million)
Table 88 RoW: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 89 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 90 Top 5 New Product Launches, Product Enhancements, and Product Approvals, 2015 & 2016
Table 91 Top 5 Agreements, Partnerships, and Collaborations, 2015 & 2016
Table 92 Product Showcase and Product Recall, 2013 & 2014
Table 93 Acquisitions, 2013 & 2014
Table 94 Top 5 Other Strategies, 2013–2015

List of Figures

Figure 1 Global Point-Of-Care Diagnostics Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Market, By Product, 2016 (USD Million)
Figure 5 Global Market, By Product, 2016 vs 2021
Figure 6 Global Market, By Prescription Mode, 2016 vs 2021
Figure 7 Global Market, By Region, 2016-2021 (USD Million)
Figure 8 Increasing Prevalence of Infectious and Lifestyle Diseases is Driving Growth in the Market
Figure 9 The Infectious Disease Testing Kits Segment in the Asia-Pacific Region to Offer Lucrative Growth Opportunities for Market Players
Figure 10 Prescription-Based Testing Kits Segment to Dominate the Market in 2016
Figure 11 Professional Diagnostic Centers to Dominate the Global Market in 2016
Figure 12 POC Diagnostics Market Segmentation
Figure 13 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Global Number HIV Patients, 2014 (Million)
Figure 15 Incidence Rate of TB in Developing Nations, 2014
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 Healthcare Decentralization Across Prominent Countries, 2013
Figure 18 Pricing Trend (2013-2018): Twofold Decline Expected in the Price of POC Devices in APAC as Compared to North America
Figure 19 Porter’s Five Forces Analysis (2016): Low Capital Requirement Increasing Competition in the Industry
Figure 20 Strategic Benchmarking: Roche and Abbott Largely Focus on Technological Integration and Product Enhancement
Figure 21 Strategic Benchmarking: Alere and Abbott Largely Adopt Strategies for Product Enhancement
Figure 22 The Infectious Disease Testing Kits Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 23 North America is Expected to Dominate the Global Point-Of-Care Diagnostics Market in 2016
Figure 24 North America is Expected to Dominate the Global Glucose Monitoring Kits Market in 2016
Figure 25 The Blood Gas/Electrolytes Segment to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 26 Asia-Pacific to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 27 North America is Expected to Dominate the Global Blood Gas/Electrolytes Market in 2016
Figure 28 Hepatitis C Testing Kits Segment to Witness Highest Growth in the Global Infectious Disease Testing Kits Market During the Forecast Period
Figure 29 North America is Expected to Dominate the Global Infectious Diseases Testing Kits Market in 2016
Figure 30 Asia-Pacific to Witness Highest Growth in the Global Hepatitis C Testing Kits Market in 2016
Figure 31 Asia-Pacific to Witness Highest Growth in the Global Hai Testing Kits Market in 2016
Figure 32 North America is Expected to Dominate the Global Pregnancy & Fertility Testing Kits Market in 2016
Figure 33 North America is Expected to Dominate the Global Hematology Testing Kits Market in 2016
Figure 34 Asia-Pacific to Witness Highest Growth in the Global Fecal Occult Testing Kits Market During the Forecast Period
Figure 35 OTC Testing Kits Segment to Witness Highest Growth During the Forecast Period
Figure 36 North America to Dominate the Prescription-Based Testing Kits Market in 2016
Figure 37 Asia-Pacific to Witness Highest Growth in the OTC Testing Kits Segment
Figure 38 Broad End-User Base for Point-Of-Care Testing Kits
Figure 39 Home Care End-User Segment to Witness Highest Growth During the Forecast Period
Figure 40 North America to Dominate the Professional Diagnostic Centers Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 42 Point-Of-Care Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Point-Of-Care Diagnostics Market Snapshot
Figure 44 Europe: Point-Of-Care Diagnostics Market Snapshot
Figure 45 APAC: Point-Of-Care Diagnostics Market Snapshot
Figure 46 Global Point-Of-Care Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: New Product Launches, Product Enhancements, and Product Approvals–Key Growth Strategy Adopted Between 2013 & 2016
Figure 48 Geographic Revenue Snapshot (2015)
Figure 49 Roche Diagnostics Limited: Company Snapshot
Figure 50 Abbott Laboratories, Inc.: Company Snapshot
Figure 51 Siemens AG: Company Snapshot
Figure 52 Alere Inc.: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Danaher Corporation: Company Snapshot
Figure 55 Becton, Dickinson and Company: Company Snapshot

  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Europe Infectious Disease Testing Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 02-Dec-2016        Price: US 19700 Onwards        Pages: 1600
    Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch.com's new five-country report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative di......
  • Europe Drugs of Abuse Testing Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 02-Dec-2016        Price: US 6500 Onwards        Pages: 300
    This new 300-page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaq......
  • 2016-2021 France Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 4450 Onwards        Pages: 897
    This new report from VPGMarketResearch contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology, an......
  • 2016-2021 Germany Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 4450 Onwards        Pages: 897
    This new report from VPGMarketResearch contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology, an......
  • 2016-2021 Italy Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 5800 Onwards        Pages: 891
    This new report from VPGMarketResearch contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology......
  • 2016-2021 Japan Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 4450 Onwards        Pages: 887
    This new report from VPGMarketResearch contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including:  Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology,......
  • 2016-2021 Spain Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 4450 Onwards        Pages: 880
    This new report from VPGMarketResearch contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology, ......
  • 2016-2021 UK Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 4450 Onwards        Pages: 886
    This new report from VPGMarketResearch contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology, and etiolo......
  • 2016-2021 US Hospital Infectious Disease Testing Market Forecasts: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review
    Published: 28-Nov-2016        Price: US 6800 Onwards        Pages: 997
    This new report from VPGMarketResearch contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on definition, epidemiology, and etiolo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs